![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir in Adolescents With Chronic Hepatitis C Virus Infection
|
|
|
AASLD 2020 Nov 11-16 virtual
Reported by Jules Levin
Sanjay Bansal,1 Magorzata Pawowska,2 Gabriella Nebbia,3 Fabiola Di Dato,4 Wojciech Suzewski,5 Vania Giacomet,6 Leszek Szenborn,7 Anna Mania,5 Jiang Shao,8 Chia-Hsiang Hsueh,8 Bandita Parhy,8 Anuj Gaggar,8 Kathryn Kersey,8 Alessandra Mangia,9 Deirdre Kelly,10 Giuseppe Indolfi11
(1)King's College Hospital, London, United Kingdom, (2)Collegium Medicum in Bydgoszcz Nicolaus Copernicus University in Torun, Poland, (3)Fondazione Irccs Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy, (4)University of Naples Federico II, Naples, Italy, (5)Karol Marcinkowski University of Medical Sciences, Poznan, Poland, (6)Luigi Sacco Hospital, University of Milan, Milan, Italy, (7)Medical University Wrocaw, Wrocaw, Poland, (8)Gilead Sciences, Inc, Foster City, CA, USA, (9)Ospedale Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy, (10)Liver Unit, Birmingham Women's & Children's Hospital and University of Birmingham, Birmingham, UK, (11)Meyer Children's University Hospital and University of of Florence, Florence, Italy
![1116201](../images/111620/111620-9/1116201.gif)
![1116202](../images/111620/111620-9/1116202.gif)
![1116203](../images/111620/111620-9/1116203.gif)
![1116204](../images/111620/111620-9/1116204.gif)
![1116205](../images/111620/111620-9/1116205.gif)
![1116206](../images/111620/111620-9/1116206.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|